Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.31 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.31 |
| ▸ | RELA | Q04206 | 2/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.30 |
| ▸ | RAF1 | P04049 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28281587 | 0.70 | CYP1A2 (0.34) | CYP2C19CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL86407 | 0.69 | ATM (0.56) | CYP2C19NFKB1NFKB2RELAALDH1A1 | |
| Hno SCHEMBL6475533 | 0.67 | ATM (0.54) | CYP2C19NFKB1NFKB2RELAALDH1A1 | |
| SCHEMBL28410604 | 0.65 | CYP1A2 (0.38) | CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7 | |
| SCHEMBL29088602 | 0.65 | KMT2A (0.39) | ALDH1A1HPGDCYP1A2 | |
| SCHEMBL28706739 | 0.65 | CYP2A6 (0.38) | CYP2C19NFKB1NFKB2RELAKDM4E | |
| Benzoquinone SCHEMBL28737726 | 0.65 | ATM (0.51) | CYP2C19NFKB1NFKB2RELAALDH1A1 | |
| Benzoquinone SCHEMBL23209758 | 0.64 | KMT2A (0.50) | CYP2C19NFKB1NFKB2RELAALDH1A1 | |
| SCHEMBL28957399 | 0.64 | HSD17B10 (0.37) | CYP2C19NFKB1NFKB2RELAKDM4E | |
| SCHEMBL7587340 | 0.62 | NFKB1 (0.42) | CYP2C19NFKB1NFKB2RELAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160237346-A1 | PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2016-08-18 | — | — | US | disclosed |
| US-20160237346-A1 | PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS | EVONIK DEGUSSA GMBH (DE) | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160237346-A1 | PROCESS AND COMPOSITION FOR INHIBITING THE POLYMERIZATION OF CYCLOPENTADIENE COMPOUNDS | CYC1, SQOR, UQCRB | GUSB 3347/4885CYP2C19 504/4885NFKB1 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.